 |
|
                
|
Since drugs constitute the bulk of biotechnological health care applications, and likewise both drug development and pricing is under particular governmental regulation, the book highlights the pharmaceutical sector whenever possible. Both practitioners and policy makers will find the messages in this book helpful in creating value for their stakeholders.
Eds. Raine Hermans, Morton Kamien, Martti Kulvik, Alicia Löffler, Joel Shalowitz.
Contents, authors and introduction:
2009 343 s. Hinta 40 euroa (Tuotekoodi B236) ISBN 978-951-628-481-4.
Kirjan tilaus sähköpostitse tai palaute -lomakkeen kautta.
|
This book deals with the complex dynamics of the health care sector, assessing, in particular, the risks inherent with an enforced regulation of an entire industry sector. The major focus is on value creation in general and biotechnology in particular.